A new artificial intelligence tool reportedly overcomes resolution issues of standard magnetic resonance imaging (MRI) scans with 3D images of the shoulder bones and may eliminate pre-operative use of computed tomography (CT) for total shoulder arthroplasty procedures.
An emerging artificial intelligence (AI)-powered may reinvent preoperative planning for total shoulder arthroplasty procedures.
When it comes to shoulder injuries, it is common to obtain magnetic resonance imaging (MRI) to ascertain any soft tissue damage. If there is a need for a total shoulder arthroplasty, one would usually order a computed tomography (CT) scan for preoperative planning due to superior resolution over the MRI. However, RSIP Vision says its new AI tool enables radiologists to segment and provide a resulting three-dimensional (3D) view of the shoulder bones from the MRI scan.
“Deep learning algorithms can be developed for accurate segmentation of the shoulder bones,” noted Ron Soferman, the CEO of RSIP Vision. “Neural networks are trained to process the resulting segmentation into a CT-grade segmentation, improving the original MRI resolution.”
"Using RSIP Vision's new technology, we can obtain accurate information regarding the soft tissue, as well as the osseous tissue, from a single shoulder MRI scan,” explained Shai Factor, MD, an orthopedic surgeon at Tel-Aviv Medical Center in Israel. “This provides a wide view of the clinical case and allows the surgeon to properly diagnose and choose the best surgical procedure for the patient.”
Dr. Factor said this enhancement of the MRI with AI may eliminate the need for a preoperative CT not to mention decreasing costs and radiation exposure for the patient.
“Currently, we require a CT scan for surgical planning. This takes time and adds costs to the process. With this new tool, we can treat our patients faster, and save them the exposure to radiation from CT, without compromising on accuracy and clinical outcome,” emphasized Dr. Factor.
RSIP Vision noted the vendor-neutral technology is currently available to third-party MRI manufacturers.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
Enhancing Lesions on Breast MRI: Can an Updated Kaiser Scoring Model Improve Detection?
September 26th 2024The addition of parameters such as patient age, MIP sign and associated imaging features to the Kaiser score demonstrated a 95.6 percent AUC for breast cancer detection of enhancing lesions on breast MRI in recently published research.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.